<table className="table">
  <caption><p>
    Comparison of Epidemiologic and Clinical Features of Ehrlichiosis, Anaplasmosis, and Spotted Fever Rickettsioses</p>
  </caption>
  <thead>
    <tr>
      <th rowSpan="1" colSpan="1"><p>
        Feature</p>
      </th>
      <th rowSpan="1" colSpan="1"><p>
        Ehrlichiosis</p>
      </th>
      <th rowSpan="1" colSpan="1"><p>
        Anaplasmosis</p>
      </th>
      <th rowSpan="1" colSpan="1"><p>
        Spotted Fever Rickettsioses</p>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr className="group_1-1 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Vector</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Lone Star tick</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Blacklegged deer tick</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        American dog tick, brown dog tick, Rocky Mountain wood tick, and others</p>
      </td>
    </tr>
    <tr className="group_1-2 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Geography</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Southeastern, mid-Atlantic, and south-central United States</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Northeastern and upper Midwest United States</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Throughout the United States<sup>
        a</sup></p>
      </td>
    </tr>
    <tr className="group_1-3 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Coinfection</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Not reported; potential for coinfection with STARI, Heartland virus, or Bourbon virus because of common vector</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Lyme disease, babesiosis; potential for coinfection with Powassan virus,<i>
        Borrelia miyamotoi</i>
        , or<i>
        Ehrlichia muris eauclairensis</i>
        because of common vector</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Not reported</p>
      </td>
    </tr>
    <tr className="group_1-4 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Incubation period</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        5-14 days</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        5-14 days</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        3-12 days</p>
      </td>
    </tr>
    <tr className="group_1-5 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Presenting signs and symptoms</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Fever, headache, myalgia</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Fever, headache, myalgia, chills</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Fever, headache, chills, myalgia, abdominal pain, meningismus</p>
      </td>
    </tr>
    <tr className="group_1-6 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Cutaneous signs</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Nonspecific rash in &lt;30% of adults, with median onset 5 days after fever</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Rash rare (&lt;10%)</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Maculopapular eruption in &gt;90% of patients, progressing to petechia with involvement of palms and soles; onset, median of 3 days after fever</p>
      </td>
    </tr>
    <tr className="group_1-7 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Laboratory study abnormalities</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Leukopenia, thrombocytopenia, increased serum aminotransferase levels</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Leukopenia, thrombocytopenia, increased serum aminotransferase levels</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Thrombocytopenia, increased serum aminotransferase levels, hyponatremia</p>
      </td>
    </tr>
    <tr className="group_1-8 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Diagnosis</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Morulae in monocytes (&lt;30%), acute and convalescent serologies, whole-blood PCR</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Morulae in neutrophils (~50%), acute and convalescent serologies, whole-blood PCR</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Acute and convalescent serologies, biopsy of skin with immunohistochemical analysis or skin PCR</p>
      </td>
    </tr>
    <tr className="group_1-9 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Treatment</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Doxycycline</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Doxycycline</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Doxycycline</p>
      </td>
    </tr>
    <tr className="group_1-10 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Fatality</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        3%</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        &lt;1%</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        5%-10%</p>
      </td>
    </tr>
  </tbody>
</table>